Copyright Reports & Markets. All rights reserved.

Global Cardiopulmonary Autotransfusion Systems Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope of Cardiopulmonary Autotransfusion Systems
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Cardiopulmonary Autotransfusion Systems Consumption Value by Type: 2019 Versus 2023 Versus 2030
    • 1.3.2 Unwashed ATS
    • 1.3.3 Washed ATS
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Cardiopulmonary Autotransfusion Systems Consumption Value by Application: 2019 Versus 2023 Versus 2030
    • 1.4.2 Heart Surgery
    • 1.4.3 Great Organ Transplant Surgery
    • 1.4.4 Others
  • 1.5 Global Cardiopulmonary Autotransfusion Systems Market Size & Forecast
    • 1.5.1 Global Cardiopulmonary Autotransfusion Systems Consumption Value (2019 & 2023 & 2030)
    • 1.5.2 Global Cardiopulmonary Autotransfusion Systems Sales Quantity (2019-2030)
    • 1.5.3 Global Cardiopulmonary Autotransfusion Systems Average Price (2019-2030)

2 Manufacturers Profiles

  • 2.1 Advancis Surgical
    • 2.1.1 Advancis Surgical Details
    • 2.1.2 Advancis Surgical Major Business
    • 2.1.3 Advancis Surgical Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.1.4 Advancis Surgical Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.1.5 Advancis Surgical Recent Developments/Updates
  • 2.2 Fresenius Kabi
    • 2.2.1 Fresenius Kabi Details
    • 2.2.2 Fresenius Kabi Major Business
    • 2.2.3 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.2.4 Fresenius Kabi Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.2.5 Fresenius Kabi Recent Developments/Updates
  • 2.3 Haemonetics
    • 2.3.1 Haemonetics Details
    • 2.3.2 Haemonetics Major Business
    • 2.3.3 Haemonetics Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.3.4 Haemonetics Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.3.5 Haemonetics Recent Developments/Updates
  • 2.4 LivaNova
    • 2.4.1 LivaNova Details
    • 2.4.2 LivaNova Major Business
    • 2.4.3 LivaNova Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.4.4 LivaNova Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.4.5 LivaNova Recent Developments/Updates
  • 2.5 Medtronic
    • 2.5.1 Medtronic Details
    • 2.5.2 Medtronic Major Business
    • 2.5.3 Medtronic Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.5.4 Medtronic Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.5.5 Medtronic Recent Developments/Updates
  • 2.6 Terumo
    • 2.6.1 Terumo Details
    • 2.6.2 Terumo Major Business
    • 2.6.3 Terumo Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.6.4 Terumo Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.6.5 Terumo Recent Developments/Updates
  • 2.7 Atrium Medical
    • 2.7.1 Atrium Medical Details
    • 2.7.2 Atrium Medical Major Business
    • 2.7.3 Atrium Medical Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.7.4 Atrium Medical Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.7.5 Atrium Medical Recent Developments/Updates
  • 2.8 Global Blood Resources
    • 2.8.1 Global Blood Resources Details
    • 2.8.2 Global Blood Resources Major Business
    • 2.8.3 Global Blood Resources Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.8.4 Global Blood Resources Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.8.5 Global Blood Resources Recent Developments/Updates
  • 2.9 Redax
    • 2.9.1 Redax Details
    • 2.9.2 Redax Major Business
    • 2.9.3 Redax Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.9.4 Redax Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.9.5 Redax Recent Developments/Updates
  • 2.10 Sarstedt
    • 2.10.1 Sarstedt Details
    • 2.10.2 Sarstedt Major Business
    • 2.10.3 Sarstedt Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.10.4 Sarstedt Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.10.5 Sarstedt Recent Developments/Updates
  • 2.11 Stryker
    • 2.11.1 Stryker Details
    • 2.11.2 Stryker Major Business
    • 2.11.3 Stryker Cardiopulmonary Autotransfusion Systems Product and Services
    • 2.11.4 Stryker Cardiopulmonary Autotransfusion Systems Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
    • 2.11.5 Stryker Recent Developments/Updates

3 Competitive Environment: Cardiopulmonary Autotransfusion Systems by Manufacturer

  • 3.1 Global Cardiopulmonary Autotransfusion Systems Sales Quantity by Manufacturer (2019-2024)
  • 3.2 Global Cardiopulmonary Autotransfusion Systems Revenue by Manufacturer (2019-2024)
  • 3.3 Global Cardiopulmonary Autotransfusion Systems Average Price by Manufacturer (2019-2024)
  • 3.4 Market Share Analysis (2023)
    • 3.4.1 Producer Shipments of Cardiopulmonary Autotransfusion Systems by Manufacturer Revenue ($MM) and Market Share (%): 2023
    • 3.4.2 Top 3 Cardiopulmonary Autotransfusion Systems Manufacturer Market Share in 2023
    • 3.4.2 Top 6 Cardiopulmonary Autotransfusion Systems Manufacturer Market Share in 2023
  • 3.5 Cardiopulmonary Autotransfusion Systems Market: Overall Company Footprint Analysis
    • 3.5.1 Cardiopulmonary Autotransfusion Systems Market: Region Footprint
    • 3.5.2 Cardiopulmonary Autotransfusion Systems Market: Company Product Type Footprint
    • 3.5.3 Cardiopulmonary Autotransfusion Systems Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Cardiopulmonary Autotransfusion Systems Market Size by Region
    • 4.1.1 Global Cardiopulmonary Autotransfusion Systems Sales Quantity by Region (2019-2030)
    • 4.1.2 Global Cardiopulmonary Autotransfusion Systems Consumption Value by Region (2019-2030)
    • 4.1.3 Global Cardiopulmonary Autotransfusion Systems Average Price by Region (2019-2030)
  • 4.2 North America Cardiopulmonary Autotransfusion Systems Consumption Value (2019-2030)
  • 4.3 Europe Cardiopulmonary Autotransfusion Systems Consumption Value (2019-2030)
  • 4.4 Asia-Pacific Cardiopulmonary Autotransfusion Systems Consumption Value (2019-2030)
  • 4.5 South America Cardiopulmonary Autotransfusion Systems Consumption Value (2019-2030)
  • 4.6 Middle East and Africa Cardiopulmonary Autotransfusion Systems Consumption Value (2019-2030)

5 Market Segment by Type

  • 5.1 Global Cardiopulmonary Autotransfusion Systems Sales Quantity by Type (2019-2030)
  • 5.2 Global Cardiopulmonary Autotransfusion Systems Consumption Value by Type (2019-2030)
  • 5.3 Global Cardiopulmonary Autotransfusion Systems Average Price by Type (2019-2030)

6 Market Segment by Application

  • 6.1 Global Cardiopulmonary Autotransfusion Systems Sales Quantity by Application (2019-2030)
  • 6.2 Global Cardiopulmonary Autotransfusion Systems Consumption Value by Application (2019-2030)
  • 6.3 Global Cardiopulmonary Autotransfusion Systems Average Price by Application (2019-2030)

7 North America

  • 7.1 North America Cardiopulmonary Autotransfusion Systems Sales Quantity by Type (2019-2030)
  • 7.2 North America Cardiopulmonary Autotransfusion Systems Sales Quantity by Application (2019-2030)
  • 7.3 North America Cardiopulmonary Autotransfusion Systems Market Size by Country
    • 7.3.1 North America Cardiopulmonary Autotransfusion Systems Sales Quantity by Country (2019-2030)
    • 7.3.2 North America Cardiopulmonary Autotransfusion Systems Consumption Value by Country (2019-2030)
    • 7.3.3 United States Market Size and Forecast (2019-2030)
    • 7.3.4 Canada Market Size and Forecast (2019-2030)
    • 7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe

  • 8.1 Europe Cardiopulmonary Autotransfusion Systems Sales Quantity by Type (2019-2030)
  • 8.2 Europe Cardiopulmonary Autotransfusion Systems Sales Quantity by Application (2019-2030)
  • 8.3 Europe Cardiopulmonary Autotransfusion Systems Market Size by Country
    • 8.3.1 Europe Cardiopulmonary Autotransfusion Systems Sales Quantity by Country (2019-2030)
    • 8.3.2 Europe Cardiopulmonary Autotransfusion Systems Consumption Value by Country (2019-2030)
    • 8.3.3 Germany Market Size and Forecast (2019-2030)
    • 8.3.4 France Market Size and Forecast (2019-2030)
    • 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
    • 8.3.6 Russia Market Size and Forecast (2019-2030)
    • 8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific

  • 9.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales Quantity by Type (2019-2030)
  • 9.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales Quantity by Application (2019-2030)
  • 9.3 Asia-Pacific Cardiopulmonary Autotransfusion Systems Market Size by Region
    • 9.3.1 Asia-Pacific Cardiopulmonary Autotransfusion Systems Sales Quantity by Region (2019-2030)
    • 9.3.2 Asia-Pacific Cardiopulmonary Autotransfusion Systems Consumption Value by Region (2019-2030)
    • 9.3.3 China Market Size and Forecast (2019-2030)
    • 9.3.4 Japan Market Size and Forecast (2019-2030)
    • 9.3.5 Korea Market Size and Forecast (2019-2030)
    • 9.3.6 India Market Size and Forecast (2019-2030)
    • 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
    • 9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America

  • 10.1 South America Cardiopulmonary Autotransfusion Systems Sales Quantity by Type (2019-2030)
  • 10.2 South America Cardiopulmonary Autotransfusion Systems Sales Quantity by Application (2019-2030)
  • 10.3 South America Cardiopulmonary Autotransfusion Systems Market Size by Country
    • 10.3.1 South America Cardiopulmonary Autotransfusion Systems Sales Quantity by Country (2019-2030)
    • 10.3.2 South America Cardiopulmonary Autotransfusion Systems Consumption Value by Country (2019-2030)
    • 10.3.3 Brazil Market Size and Forecast (2019-2030)
    • 10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa

  • 11.1 Middle East & Africa Cardiopulmonary Autotransfusion Systems Sales Quantity by Type (2019-2030)
  • 11.2 Middle East & Africa Cardiopulmonary Autotransfusion Systems Sales Quantity by Application (2019-2030)
  • 11.3 Middle East & Africa Cardiopulmonary Autotransfusion Systems Market Size by Country
    • 11.3.1 Middle East & Africa Cardiopulmonary Autotransfusion Systems Sales Quantity by Country (2019-2030)
    • 11.3.2 Middle East & Africa Cardiopulmonary Autotransfusion Systems Consumption Value by Country (2019-2030)
    • 11.3.3 Turkey Market Size and Forecast (2019-2030)
    • 11.3.4 Egypt Market Size and Forecast (2019-2030)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
    • 11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics

  • 12.1 Cardiopulmonary Autotransfusion Systems Market Drivers
  • 12.2 Cardiopulmonary Autotransfusion Systems Market Restraints
  • 12.3 Cardiopulmonary Autotransfusion Systems Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Cardiopulmonary Autotransfusion Systems and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Cardiopulmonary Autotransfusion Systems
  • 13.3 Cardiopulmonary Autotransfusion Systems Production Process
  • 13.4 Cardiopulmonary Autotransfusion Systems Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Cardiopulmonary Autotransfusion Systems Typical Distributors
  • 14.3 Cardiopulmonary Autotransfusion Systems Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Cardiopulmonary Autotransfusion Systems market size was valued at USD 569 million in 2023 and is forecast to a readjusted size of USD 667 million by 2030 with a CAGR of 2.3% during review period.
    Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.

    Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
    According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
    The Global Info Research report includes an overview of the development of the Cardiopulmonary Autotransfusion Systems industry chain, the market status of Heart Surgery (Unwashed ATS, Washed ATS), Great Organ Transplant Surgery (Unwashed ATS, Washed ATS), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Cardiopulmonary Autotransfusion Systems.
    Regionally, the report analyzes the Cardiopulmonary Autotransfusion Systems markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Cardiopulmonary Autotransfusion Systems market, with robust domestic demand, supportive policies, and a strong manufacturing base.
    Key Features:
    The report presents comprehensive understanding of the Cardiopulmonary Autotransfusion Systems market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Cardiopulmonary Autotransfusion Systems industry.
    The report involves analyzing the market at a macro level:
    Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Unwashed ATS, Washed ATS).
    Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Cardiopulmonary Autotransfusion Systems market.
    Regional Analysis: The report involves examining the Cardiopulmonary Autotransfusion Systems market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
    Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Cardiopulmonary Autotransfusion Systems market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
    The report also involves a more granular approach to Cardiopulmonary Autotransfusion Systems:
    Company Analysis: Report covers individual Cardiopulmonary Autotransfusion Systems manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
    Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Cardiopulmonary Autotransfusion Systems This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Heart Surgery, Great Organ Transplant Surgery).
    Technology Analysis: Report covers specific technologies relevant to Cardiopulmonary Autotransfusion Systems. It assesses the current state, advancements, and potential future developments in Cardiopulmonary Autotransfusion Systems areas.
    Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Cardiopulmonary Autotransfusion Systems market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
    Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
    Market Segmentation
    Cardiopulmonary Autotransfusion Systems market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
    Market segment by Type
    Unwashed ATS
    Washed ATS
    Market segment by Application
    Heart Surgery
    Great Organ Transplant Surgery
    Others
    Major players covered
    Advancis Surgical
    Fresenius Kabi
    Haemonetics
    LivaNova
    Medtronic
    Terumo
    Atrium Medical
    Global Blood Resources
    Redax
    Sarstedt
    Stryker
    Market segment by region, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Cardiopulmonary Autotransfusion Systems product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Cardiopulmonary Autotransfusion Systems, with price, sales, revenue and global market share of Cardiopulmonary Autotransfusion Systems from 2019 to 2024.
    Chapter 3, the Cardiopulmonary Autotransfusion Systems competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Cardiopulmonary Autotransfusion Systems breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
    Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Cardiopulmonary Autotransfusion Systems market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
    Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Cardiopulmonary Autotransfusion Systems.
    Chapter 14 and 15, to describe Cardiopulmonary Autotransfusion Systems sales channel, distributors, customers, research findings and conclusion.

    Buy now